Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.02 ng/ml | Cytotoxicity against human A549 cells after 72 hrs by SRB assay | ChEMBL. | 10096868 |
IC50 (functional) | = 0.03 ng/ml | Cytotoxicity against human XF498 cells after 72 hrs by SRB assay | ChEMBL. | 10096868 |
IC50 (functional) | = 0.04 ng/ml | Cytotoxicity against human SKOV3 cells after 72 hrs by SRB assay | ChEMBL. | 10096868 |
IC50 (functional) | = 0.06 ng/ml | Cytotoxicity against human HCT-15 cells after 72 hrs by SRB assay | ChEMBL. | 10096868 |
IC50 (functional) | = 8.5 ng/ml | Cytotoxicity against human SK-MEL-2 cells after 72 hrs by SRB assay | ChEMBL. | 10096868 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 10096868 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.